OSI Investment Management

OSI Investment Management operates as a venture capital firm, functioning as a subsidiary of OSI Pharmaceuticals. It strategically invests in life sciences companies, focusing on early-stage innovation and development within the biopharmaceutical sector. This approach leverages the parent company's extensive expertise to identify and support promising technologies and therapeutic candidates.

Established as the venture capital arm of OSI Pharmaceuticals, OSI Investment Management's founding reflected the parent company's strategic vision to foster external innovation. Its inception was driven by the insight that actively funding and partnering with pioneering startups could significantly expand OSI Pharmaceuticals' pipeline and influence in the dynamic biopharmaceutical landscape.

The firm’s focus is on promising life sciences startups, particularly in biotech and pharmaceutical development. Providing capital and strategic guidance, OSI Investment Management accelerates the growth of these ventures. Its long-term vision is to cultivate a robust ecosystem of innovative companies, thereby contributing to the advancement of medical science and delivering novel therapies to patients.